Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


A Personal Touch Can Help Medication Adherence, Mass General Finds

Executive Summary

As themes of patient-centered outcomes and personalized medicine become more common in drug development, the concepts also are playing out in the medication adherence space, as shown in a program at Massachusetts General Hospital.

You may also be interested in...

PCORI Approves 45 CER Projects

The Patient-Centered Outcomes Research Institute awarded 45 grants for comparative effectiveness research in its Dec. 17 announcement, which included the first drug vs. drug clinical trial for neuropathy and studies of medication adherence.

Rx Adherence Advocates Target Coming Medicare “Doc Fix” Bill With Policy Recommendations

Council for Affordable Health Coverage is lobbying for policies around medication synchronization and better use of health IT, with an eye on using CBO’s scoring of savings from medication use to help pay for reforming Medicare’s physician payment updating method in upcoming legislation.

Merck-Backed Medication Adherence Plan Says Reducing Copays Is Part Of The Solution

National Council on Patient Information and Education releases a series of recommendations aimed at improving medication adherence in a campaign supported by Merck.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts